Lead study investigator Dr. Bruce Sands, Icahn School of Medicine, Mt. Sinai, New York discusses Janssen’s announcement of their new two-year data from the long-term extension of the Phase 3 UNIFI study of STELARA® (ustekinumab) that demonstrated long term efficacy and safety in adult patients with moderate to severe ulcerative colitis. This was presented as late-breaking data at the 27th United European Gastroenterology Week (UEGW) congress.
Dr. Heidi Godoy discusses what it means to have ovarian cancer, the latest in treatment options for recurrent ovarian cancer and how they work. She encourages women with recurrent ovarian cancer to have a conversation with their physician about treatment options. She is joined by Anna, a woman living with recurrent ovarian cancer who will share her experience with this disease.
Dr. Elizabeth Cherot talks about advances in opioid alternatives, shares what she’s doing to help her patients and encourages women to speak with their doctor about effective non-opioid options to manage pain after surgery including C-sections.
Ed Sandrick, Director of the Veterans Channel for Humana, shares helpful information for veterans to better understand how a Medicare Advantage plan can help round out the coverage provided by VA benefits, allowing veterans to maximize their health benefits and ensure they have the right health Medicare plan in place come January 1.
Dr. Phyllis Zee, discusses the results of the “How America Sleeps and Wakes” survey conducted by The Harris Poll and sponsored by Eisai Inc., that evaluated the perceptions of insomnia patients and household cohabitants regarding the burden of insomnia and sleep difficulties on having a good day.
Rich Purcell, Senior VP of Research & Drug Development at Generex Biotechnology, discusses the NuGenerex MSO (managed services organization) model, areas of healthcare where strategic improvements can make a significant impact, gaps within traditional MSOs and specialties where new models can work best, and how drug discovery and development can be accelerated with revenue-generating business models.
Berndt Modig, CEO, and Dr. Jochen Knolle, CSO, discuss Pharvaris, a clinical-stage company focused on developing oral therapies for hereditary angioedema (HAE) patients. Hereditary angioedema is a rare and potentially life-threatening genetic condition with incidence between 1 in 10,000 and 1 in 50,000 people. Current therapies are limited by invasive routes of drug administration (injection or infusion), inconvenient dosing regimens, or undesired side effects.
Returning guest Bill Rancic is joined by his wife Giuliana to discuss Giuliana’s experience with cancer and how Bill’s role as a caregiver served as the impetus for them to partner with Astellas Oncology on the C3 Prize (Changing Cancer Care), an annual competition to identify creative ideas to improve the lives of people touched by cancer. They discuss the winners and how the grants (totaling $200K) and resources (professional TEDMED Coaching) will be used to bring the ideas to life and they talk about their latest projects.
Young MDs getting into the field are expressing more and more interest in their job options, including the role of chief medical informatics officer, according to Benjamin Kanter, MD, CMIO of Vocera. That may be the result of daily stories on clinician burnout, or the exciting digital transformation happening in healthcare. Dr. Kanter joins us today to discuss his journey from practicing physician to CMIO. He often consults with medical students about merging their passions for IT and medical school. Often, such students only hear about traditional physician roles – and never about physicians as administrators, or physicians as tech innovators. Dr. Kanter believes that has to change.